190 related articles for article (PubMed ID: 31931292)
1. Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
Ng SP; Bahig H; Jethanandani A; Pollard C; Berends J; Sturgis EM; Johnson FM; Elgohari B; Elhalawani H; Rosenthal DI; Skinner HD; Gunn GB; Phan J; Frank SJ; Mohamed ASR; Fuller CD; Garden AS
Radiother Oncol; 2020 Apr; 145():95-100. PubMed ID: 31931292
[TBL] [Abstract][Full Text] [Related]
2. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
[TBL] [Abstract][Full Text] [Related]
3. Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A
Ni W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J
Front Oncol; 2022; 12():936684. PubMed ID: 36158699
[TBL] [Abstract][Full Text] [Related]
4. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
5. A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer.
Xu Z; Yang L; Yu H; Guo L
Front Oncol; 2022; 12():905222. PubMed ID: 36185193
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
7. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
8. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy.
Ladbury CJ; Rusthoven CG; Camidge DR; Kavanagh BD; Nath SK
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):346-355. PubMed ID: 31175902
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy.
Terrones-Campos C; Ledergerber B; Vogelius IR; Specht L; Helleberg M; Lundgren J
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):812-823. PubMed ID: 31344435
[TBL] [Abstract][Full Text] [Related]
10. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
11. Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.
Burr AR; Harari PM; Ko HC; Bruce JY; Kimple RJ; Witek ME
Oral Oncol; 2019 May; 92():52-56. PubMed ID: 31010623
[TBL] [Abstract][Full Text] [Related]
12. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
14. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
[TBL] [Abstract][Full Text] [Related]
15. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
16. Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer.
Yang L; Xu Z; Ma L; Liu Q; Chang ATY; Wang Q; Zha J; Zhang J; Jiang X; Zhang J; Kong FS; Guo L
Cancer Biomark; 2022; 34(1):149-159. PubMed ID: 35094986
[TBL] [Abstract][Full Text] [Related]
17. Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort.
Byun HK; Chung SY; Kim KJ; Seong J
Cancer Res Treat; 2021 Oct; 53(4):962-972. PubMed ID: 33540496
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy.
Abravan A; Eide HA; Helland Å; Malinen E
Clin Transl Radiat Oncol; 2020 May; 22():15-21. PubMed ID: 32181373
[TBL] [Abstract][Full Text] [Related]
19. Definitive intensity-modulated radiotherapy concurrent with systemic therapy for oropharyngeal squamous cell carcinoma: Outcomes from an integrated regional Australian cancer centre.
Masoud Rahbari R; Winkley L; Hill J; Tahir AR; McKay M; Last A; Shakespeare TP; Dwyer P
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):414-9. PubMed ID: 26786975
[TBL] [Abstract][Full Text] [Related]
20. Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.
Söderström K; Nilsson P; Dalianis T; Kjellén E; Zackrisson B
Radiat Oncol; 2015 May; 10():117. PubMed ID: 26014350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
